On January 28, 2015, Judge Mitchell Goldberg of the U.S. District Court for the Eastern District of Pennsylvania denied defendants’ summary judgment motions, sending the second reverse-payment-settlement case to trial. In King Drug Company of Florence v. Cephalon, Judge Goldberg found that plaintiffs “satisfied their burden of presenting evidence of anticompetitive effects” and that there … Continue reading Prof. Carrier article on Cephalon case…
Category: News
Professor Carrier podcast with Northwestern Law Review
This podcast discusses and elaborates on Professor Carrier’s essay, in which he explores two recent district court decisions that could frustrate the Supreme Court’s recent directive to apply antitrust law to “exclusion payment” patent settlements. The Court’s high-profile Actavis decision set broad guidelines for lower courts on how to assess the settlements, in which a … Continue reading Professor Carrier podcast with Northwestern Law Review…
RIIPL conference: Feb. 27 at USF Law School
RIIPL conference: After Actavis: Litigating Reverse Payments Register Now Since the landmark United States Supreme Court decision in FTC v. Actavis, courts use the rule of reason to scrutinize payments from brand drug companies to generic drug companies in settling patent infringement cases. But how should they do so? What must plaintiffs show to invoke … Continue reading RIIPL conference: Feb. 27 at USF Law School…
Professor Ellen Goodman to Speak on European Right to be Forgotten
OF SEARCH ENGINES, UNFOLDING JURISDICTION AND THE CLAIMS OF PRIVACY: THE DRAMA OF INTERNET POLICY AND THE RIGHT TO BE FORGOTTEN JANUARY 29, 2015 06:00PM – 08:00PM CARDOZO SCHOOL OF LAW, ROOM 206 55 FIFTH AVENUE NEW YORK CITY, Panel Discussion Featuring Professor Ellen Goodman (Rutgers University) and Marcel Leonardi (Senior Public Policy Counsel, Google) The European Court … Continue reading Professor Ellen Goodman to Speak on European Right to be Forgotten…
WSJ’s Q&A with Michael Carrier
The Wall Street Journal published Why the FTC Lawsuit over Pay-To-Delay Deals Matters – Carrier Explains, a Q&A with Michael Carrier. Carrier discussed the Federal Trade Commission’s lawsuit, which alleged antitrust violations by Abbott for filing frivolous patent litigation and by Abbott and Teva for entering into a settlement to delay generic entry. Carrier explained … Continue reading WSJ’s Q&A with Michael Carrier…